Article and Video CATEGORIES
Dr. Alankrita Taneja's interest lie in hematological malignancies including lymphoma and multiple myeloma, with a special interest in cellular therapies. She also did a course in global and urban health equity while in residency and she is interested in health disparities and equitable care.
For more information, visit https://www.roswellpark.org/alankrita-taneja
Dr. Alankrita Taneja discusses issues surrounding the transgender community in India, including possible side effects of gender-affirming therapy.
डॉ। अलंकृता तनेजा भारत में ट्रांसजेंडर समुदाय से जुड़ी मुद्दों पर चर्चा करती हैं, जिसमें जेंडर अफर्मिंग थेरेपी के संभव दुष्प्रभाव भी शामिल हैं।
To watch the complete HPV Program series, visit the full video playlist here.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's beautiful Linda. Thank you,